BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salvi V, Mencacci C, Barone-Adesi F. H1-histamine receptor affinity predicts weight gain with antidepressants. Eur Neuropsychopharmacol 2016;26:1673-7. [PMID: 27593622 DOI: 10.1016/j.euroneuro.2016.08.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Fusar-Poli L, Amerio A, Cimpoesu P, Natale A, Salvi V, Zappa G, Serafini G, Amore M, Aguglia E, Aguglia A. Lipid and Glycemic Profiles in Patients with Bipolar Disorder: Cholesterol Levels Are Reduced in Mania. Medicina (Kaunas) 2020;57:28. [PMID: 33396922 DOI: 10.3390/medicina57010028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Olten B, Bloch MH. Meta regression: Relationship between antipsychotic receptor binding profiles and side-effects. Prog Neuropsychopharmacol Biol Psychiatry 2018;84:272-81. [PMID: 29410000 DOI: 10.1016/j.pnpbp.2018.01.023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
3 Galimberti F, Casula M, Scotti L, Olmastroni E, Ferrante D, Ucciero A, Tragni E, Catapano AL, Barone-Adesi F. Potentially Inappropriate Prescribing among Elderly Outpatients: Evaluation of Temporal Trends 2012-2018 in Piedmont, Italy. Int J Environ Res Public Health 2022;19:3612. [PMID: 35329299 DOI: 10.3390/ijerph19063612] [Reference Citation Analysis]
4 Gruener AM, Jolly AD, Ellison JMA, Burdon MA. Weighing the Risks and Benefits of Antidepressants in Idiopathic Intracranial Hypertension. J Neuroophthalmol 2018;38:128-9. [PMID: 29135815 DOI: 10.1097/WNO.0000000000000595] [Reference Citation Analysis]
5 Telang S, Walton C, Olten B, Bloch MH. Meta-analysis: Second generation antidepressants and headache. J Affect Disord 2018;236:60-8. [PMID: 29715610 DOI: 10.1016/j.jad.2018.04.047] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Sepede G, Di Iorio G, Sarchione F, Fiori F, Di Giannantonio M. Bupropion Augmentation in a Case of Compulsive Buying Disorder. Clin Neuropharmacol 2017;40:189-91. [PMID: 28622206 DOI: 10.1097/WNF.0000000000000232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
7 Kao AC, Burnet PWJ, Lennox BR. Can prebiotics assist in the management of cognition and weight gain in schizophrenia? Psychoneuroendocrinology 2018;95:179-85. [PMID: 29883788 DOI: 10.1016/j.psyneuen.2018.05.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
8 Firth J, Teasdale SB, Allott K, Siskind D, Marx W, Cotter J, Veronese N, Schuch F, Smith L, Solmi M, Carvalho AF, Vancampfort D, Berk M, Stubbs B, Sarris J. The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry 2019;18:308-24. [PMID: 31496103 DOI: 10.1002/wps.20672] [Cited by in Crossref: 97] [Cited by in F6Publishing: 82] [Article Influence: 32.3] [Reference Citation Analysis]
9 Dandjinou M, Sheehy O, Bérard A. Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case-control study. BMJ Open 2019;9:e025908. [PMID: 31575566 DOI: 10.1136/bmjopen-2018-025908] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
10 Stępnicki P, Kondej M, Kaczor AA. Current Concepts and Treatments of Schizophrenia. Molecules 2018;23:E2087. [PMID: 30127324 DOI: 10.3390/molecules23082087] [Cited by in Crossref: 72] [Cited by in F6Publishing: 46] [Article Influence: 18.0] [Reference Citation Analysis]
11 Aguglia A, Signorelli MS, Albert U, Maina G. The Impact of General Medical Conditions in Obsessive-Compulsive Disorder. Psychiatry Investig 2018;15:246-53. [PMID: 29475243 DOI: 10.30773/pi.2017.06.17.2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
12 Johannes CM, Musser ML. Anorexia and the Cancer Patient. Vet Clin North Am Small Anim Pract 2019;49:837-54. [PMID: 31176457 DOI: 10.1016/j.cvsm.2019.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Aguglia A, Salvi V, Amerio A, Gari M, Dragogna F, Mencacci C, Volpe U, Serafini G, Amore M. Number of episodes and duration of illness associated with hypertension and 10-year cardiovascular risk in patients with bipolar disorder type I. Psychiatry Research 2022;308:114344. [DOI: 10.1016/j.psychres.2021.114344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Pfanzagl B, Mechtcheriakova D, Meshcheryakova A, Aberle SW, Pfragner R, Jensen-Jarolim E. Activation of the ileal neuroendocrine tumor cell line P-STS by acetylcholine is amplified by histamine: role of H3R and H4R. Sci Rep 2017;7:1313. [PMID: 28465562 DOI: 10.1038/s41598-017-01453-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
15 Lupattelli A, Barone-Adesi F, Nordeng H. Association between antidepressant use in pregnancy and gestational diabetes mellitus: Results from the Norwegian Mother, Father and Child Cohort Study. Pharmacoepidemiol Drug Saf 2021. [PMID: 34817916 DOI: 10.1002/pds.5388] [Reference Citation Analysis]
16 Kahl KG, Stapel B, Correll CU. Psychological and Psychopharmacological Interventions in Psychocardiology. Front Psychiatry 2022;13:831359. [DOI: 10.3389/fpsyt.2022.831359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Mazereel V, Detraux J, Vancampfort D, van Winkel R, De Hert M. Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness. Front Endocrinol (Lausanne) 2020;11:573479. [PMID: 33162935 DOI: 10.3389/fendo.2020.573479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Kahl KG, Westhoff-bleck M, Krüger TH. Effects of psychopharmacological treatment with antidepressants on the vascular system. Vascular Pharmacology 2017;96-98:11-8. [DOI: 10.1016/j.vph.2017.07.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
19 Tiwari AK, Zhang D, Pouget JG, Zai CC, Chowdhury NI, Brandl EJ, Qin L, Freeman N, Lieberman JA, Meltzer HY, Kennedy JL, Müller DJ. Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain. The World Journal of Biological Psychiatry 2018;19:S97-S105. [DOI: 10.1080/15622975.2016.1262061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
20 Vasileva SS, Tucker J, Siskind D, Eyles D. Does the gut microbiome mediate antipsychotic-induced metabolic side effects in schizophrenia? Expert Opin Drug Saf 2022. [PMID: 35189774 DOI: 10.1080/14740338.2022.2042251] [Reference Citation Analysis]
21 Kahl KG. Direct and indirect effects of psychopharmacological treatment on the cardiovascular system. Horm Mol Biol Clin Investig 2018;36. [PMID: 30427780 DOI: 10.1515/hmbci-2018-0054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
22 Kuo H, Chen H, Lee C, Lee H, Kuo C, Hsu C, Pan C, Su N, Chu C. Antidepressants and Risk of Type 2 Diabetes Mellitus: A Population-Based Nested Case-Control Study. J Clin Psychopharmacol 2020;40:359-65. [DOI: 10.1097/jcp.0000000000001228] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Vasyuk YA, Dovzhenko TV, Dubrovskaya TI, Nesterova EA, Shupenina EY. [Characteristics of arterial hypertension clinical course in patients with obesity and anxiety-depressive disorders]. Ter Arkh 2021;93:94-9. [PMID: 33720633 DOI: 10.26442/00403660.2021.01.200567] [Reference Citation Analysis]
24 Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S. Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression. Prog Neuropsychopharmacol Biol Psychiatry 2019;94:109638. [PMID: 31054944 DOI: 10.1016/j.pnpbp.2019.109638] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
25 Grajales D, Ferreira V, Valverde ÁM. Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain. Cells 2019;8:E1336. [PMID: 31671770 DOI: 10.3390/cells8111336] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 8.7] [Reference Citation Analysis]
26 Vanoli J, Nava CR, Airoldi C, Ucciero A, Salvi V, Barone-Adesi F. Use of State Sequence Analysis in Pharmacoepidemiology: A Tutorial. Int J Environ Res Public Health 2021;18:13398. [PMID: 34949007 DOI: 10.3390/ijerph182413398] [Reference Citation Analysis]
27 Nguyen TTH, Roussin A, Rousseau V, Montastruc J, Montastruc F. Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological–Pharmacodynamic Study in VigiBase®. Drug Saf 2018;41:1087-96. [DOI: 10.1007/s40264-018-0693-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
28 Salvi V, Grua I, Cerveri G, Mencacci C, Barone-Adesi F. The risk of new-onset diabetes in antidepressant users - A systematic review and meta-analysis. PLoS One 2017;12:e0182088. [PMID: 28759599 DOI: 10.1371/journal.pone.0182088] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
29 Alonso-Pedrero L, Bes-Rastrollo M, Marti A. Effects of antidepressant and antipsychotic use on weight gain: A systematic review. Obes Rev 2019;20:1680-90. [PMID: 31524318 DOI: 10.1111/obr.12934] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
30 Franx BAA, Arnoldussen IAC, Kiliaan AJ, Gustafson DR. Weight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy. Drugs Aging 2017;34:425-36. [PMID: 28478593 DOI: 10.1007/s40266-017-0462-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]